Citigroup
TMCI icon

Citigroup’s Treace Medical Concepts TMCI Stock Holding History

Citigroup’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,533
Closed -$3.39K – 6243
2026
Q1 		$3.39K Sell
2,533
-11,743
-82% -$23.4K ﹤0.01% 5345
2025
Q4 		$35K Buy
14,276
+8,404
+143% +$36.5K ﹤0.01% 4696
2025
Q3 		$39.4K Sell
5,872
-11,636
-66% -$76K ﹤0.01% 4566
2025
Q2 		$103K Sell
17,508
-17,750
-50% -$116K ﹤0.01% 4391
2025
Q1 		$296K Sell
35,258
-4,326
-11% -$38.9K ﹤0.01% 3961
2024
Q4 		$295K Buy
39,584
+4,162
+12% +$27.8K ﹤0.01% 4158
2024
Q3 		$205K Buy
35,422
+17,923
+102% +$115K ﹤0.01% 4328
2024
Q2 		$116K Buy
17,499
+9,937
+131% +$80.3K ﹤0.01% 4138
2024
Q1 		$98.7K Buy
7,562
+1,030
+16% +$13.7K ﹤0.01% 4302
2023
Q4 		$83.3K Buy
6,532
+6,421
+5,785% +$64.9K ﹤0.01% 4278
2023
Q3 		$1.46K Sell
111
-14,357
-99% -$263K ﹤0.01% 5033
2023
Q2 		$370K Buy
14,468
+14,050
+3,361% +$363K ﹤0.01% 3565
2023
Q1 		$10.5K Sell
418
-222
-35% -$5.21K ﹤0.01% 4708
2022
Q4 		$14.7K Sell
640
-274
-30% -$6.31K ﹤0.01% 4712
2022
Q3 		$20K Sell
914
-1,632
-64% -$31.6K ﹤0.01% 4752
2022
Q2 		$37K Buy
2,546
+957
+60% +$16.1K ﹤0.01% 4678
2022
Q1 		$30K Sell
1,589
-6,624
-81% -$129K ﹤0.01% 4955
2021
Q4 		$153K Buy
8,213
+6,899
+525% +$142K ﹤0.01% 4504
2021
Q3 		$35K Buy
1,314
+484
+58% +$13.3K ﹤0.01% 4952
2021
Q2 		$26K Buy
+830
New +$26.4K ﹤0.01% 5165

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Citigroup's TMCI Position: Q2 2026 in Review

Citigroup sold out of Treace Medical Concepts (TMCI) in Q2 2026, closing a stake of 2,533 shares — an estimated $3.39K sold.

Citigroup first reported a position in TMCI in Q2 2021 and held it in 20 quarters. The position peaked at $370K in Q2 2023. 117 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Citigroup reported no remaining Treace Medical Concepts position as of Q2 2026 after selling out during the quarter.
  • Citigroup sold 2,533 Treace Medical Concepts shares in Q2 2026, an estimated $3.39K.
  • Citigroup first reported a position in Treace Medical Concepts in Q2 2021 and held it in 20 quarters.
  • Citigroup's Treace Medical Concepts position peaked at $370K in Q2 2023.
  • 117 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.